News
4don MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose.
1don MSN
Got the sniffles? Here’s what to know about summer colds and the COVID-19 variant called stratus
COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S.
LONDON (Reuters) -Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results